The Corn Lab

The Corn Lab develops and uses next-generation genome editing and regulation technologies. We work on both fundamental biological discovery and potential therapies for human genetic diseases. Our focus is the mechanisms by which cells repair their DNA, maintain and differentiate hematopoietic stem cells, and dispose of entire organelles. Through technology development, mechanistic cellular biochemistry, and translational projects, we are working to unravel complex cellular phenotypes to further biological understanding and improve human health.

Our work is supported by the Swiss National Science Foundation, the European Research Council, the NCCR RNA & Disease, the Fanconi Anemia Research Fund, the Bill and Melinda Gates Foundation, the NOMIS Foundation, and the Lotte and Adolf Hotz-Sprenger Foundation.

News

October 31, 2023

Welcome to Dominic!

Dominic Mailänder received his Bachelor’s degree in Biology from ETH Zürich in 2022. He is currently enrolled in the Molecular Health Sciences Master’s...

October 6, 2023

Welcome to Marwa!

Marwa Peters Al-Bayati received her MSc in Biology from ETH Zurich in February 2023. Marwa joined the Corn Lab as a PhD student in March 2023.  Her research interests...

September 8, 2023

THE EXPLAINER VIDEO FEATURING OUR HBD PROMOTER RESEARCH IS NOW LIVE!

Check out our new animated video highlighting Mandy’s research on HBD promoter engineering!

 

To learn more, please refer to this article on Elife...

News Archive

Tweets

Contact Us

Questions and/or comments about Corn Lab and its activities may be addressed to:

JACOB.CORN@BIOL.ETHZ.CH

Share: